Objective: As fine needle aspiration cytology (FNAC) is the primary tool for evaluation of breast lesions, it is essential to segregate lesions with low and high risk of malignancy. To address this, Masood proposed a cytological scoring system for categorization, Masood’s Scoring Index (MSI), which was modified later (Modified Masood’s Scoring Index [MMSI]). This study analyses the effectiveness of MMSI over MSI and assesses the concordance between cytological scoring and histopathology. Study Design: All breast FNACs over a period of 2 years were categorized based on MSI and MMSI by 2 reviewers independently. The agreement rate along with specificity, sensitivity, positive predictive value, negative predictive value and diagnostic accuracy were calculated. Correlation and concordance analyses between cytological and histopathological categories were conducted. Results and Discussion: Out of 415 cases of breast FNACs, histopathology was available for 310 for which MSI and MMSI were evaluated. The sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy were 95, 100, 100, 97.6 and 98.3%, respectively. The difference between the concordance rate of MSI and of MMSI for various cytological categories was found to be statistically significant. Conclusion: MMSI has a better concordance with histopathological diagnosis than MSI. MMSI can serve as a uniform standardized scoring system for breast cytology for better categorization of proliferative breast diseases.

1.
Singh
P
,
Chaudhry
M
,
Nauhria
S
,
Rao
D
.
Cytomorphological patterns of breast lesions diagnosed on fine-needle aspiration cytology in a tertiary care hospital
.
Int J Med Sci Public Health
.
2015
;
4
(
5
):
674
9
. 2320-4664
2.
Frost
AR
,
Tabbara
SO
,
Poprocky
LA
,
Weiss
H
,
Sidawy
MK
.
Cytologic features of proliferative breast disease: a study designed to minimize sampling error
.
Cancer
.
2000
Feb
;
90
(
1
):
33
40
.
[PubMed]
0008-543X
3.
Bansal
C
,
Pujani
M
,
Sharma
KL
,
Srivastava
AN
,
Singh
US
.
Grading systems in the cytological diagnosis of breast cancer: a review
.
J Cancer Res Ther
.
2014
Oct-Dec
;
10
(
4
):
839
45
.
[PubMed]
0973-1482
4.
Nandini
NM
,
Rekha
TS
,
Manjunath
GV
.
Evaluation of scoring system in cytological diagnosis and management of breast lesion with review of literature
.
Indian J Cancer
.
2011
Apr-Jun
;
48
(
2
):
240
5
.
[PubMed]
0019-509X
5.
Masood
S
,
Frykberg
ER
,
McLellan
GL
,
Scalapino
MC
,
Mitchum
DG
,
Bullard
JB
.
Prospective evaluation of radiologically directed fine-needle aspiration biopsy of nonpalpable breast lesions
.
Cancer
.
1990
Oct
;
66
(
7
):
1480
7
.
[PubMed]
0008-543X
6.
Semwal
S
,
Joshi
D
,
Khare
A
,
Goel
G
,
Kapoor
N
.
Validation and Modification of the Masood Scoring Index for the Diagnosis of Atypical Breast Lesions
.
Acta Cytol
.
2017
;
61
(
2
):
111
6
.
[PubMed]
0001-5547
7.
Dawson
AE
,
Mulford
DK
,
Sheils
LA
.
The cytopathology of proliferative breast disease. Comparison with features of ductal carcinoma in situ
.
Am J Clin Pathol
.
1995
Apr
;
103
(
4
):
438
42
.
[PubMed]
0002-9173
8.
Lester
SC
. The Breast. In: Kumar V, Abbas AK, Aster JC editor Robibins & Cotran Pathologic basis of Disease. 9th ed. South Asia: Elsevier
2014
. pp. 1043-72.
9.
Masood
S
.
Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions
.
Clin Lab Med
.
2005
Dec
;
25
(
4
):
713
31
.
[PubMed]
0272-2712
10.
Cherath
SK
,
Chithrabhanu
SM
.
Evaluation of Masood’s and Modified Masood’s Scoring Systems in the Cytological Diagnosis of Palpable Breast Lump Aspirates
.
J Clin Diagn Res
.
2017
Apr
;
11
(
4
):
EC06
10
.
[PubMed]
2249-782X
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.